Literature DB >> 28861756

Management of Supraventricular Tachycardia in Infants.

Chalese Richardson1, Eric S Silver2.   

Abstract

Supraventricular tachycardia is the most common tachyarrhythmia encountered in infants. In older children and adults, definitive treatment of the supraventricular tachycardia substrate with catheter ablation is a common approach to management. However, in infants, the risks of catheter ablation are significantly higher, and the patients often outgrow the potential to experience episodes. Therefore, antiarrhythmic medications are often utilized to minimize the likelihood of experiencing episodes. This article reviews the common arrhythmia mechanisms encountered in infants and the medications used to treat these patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28861756     DOI: 10.1007/s40272-017-0254-0

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  68 in total

1.  Adenosine: clinical pharmacology and applications.

Authors:  C R Conti
Journal:  Clin Cardiol       Date:  1991-02       Impact factor: 2.882

2.  Paroxysmal tachycardia in infancy: follow-up study of 47 subjects ranging in age from 10 to 26 years.

Authors:  A Lundberg
Journal:  Pediatrics       Date:  1973-01       Impact factor: 7.124

3.  Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.

Authors:  J P Saul; M S Schaffer; P P Karpawich; C C Erickson; M R Epstein; A P Melikian; J Shi; A H Karara; B Cai; P H Hinderling
Journal:  J Clin Pharmacol       Date:  2001-01       Impact factor: 3.126

4.  Electrophysiologic studies of supraventricular tachycardia in children. I. Clinical-electrophysiologic correlations.

Authors:  A Garson; P C Gillette
Journal:  Am Heart J       Date:  1981-08       Impact factor: 4.749

5.  Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.

Authors:  P Coumel; J Fidelle
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

6.  Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.

Authors:  A L Fenrich; J C Perry; R A Friedman
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

7.  Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children < 3 or > or =3 years of age.

Authors:  Jack C Salerno; Naomi J Kertesz; Richard A Friedman; Arnold L Fenrich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

8.  Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children.

Authors:  B F Cuneo; V R Zales; P C Blahunka; D W Benson
Journal:  Pediatr Cardiol       Date:  1994 Nov-Dec       Impact factor: 1.655

9.  Paroxysmal tachycardia in infants and children; study of 41 cases.

Authors:  A S NADAS; C W DAESCHNER; A ROTH; S L BLUMENTHAL
Journal:  Pediatrics       Date:  1952-02       Impact factor: 7.124

10.  Flecainide as first-line treatment for supraventricular tachycardia in newborns.

Authors:  Marco Ferlini; Anna M Colli; Carla Bonanomi; Laura Salvini; Maria A Galli; Patrizia Salice; Romana Ravaglia; Marco Centola; Gian B Danzi
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-05       Impact factor: 2.160

View more
  2 in total

1.  Slowing down in the fast lane: could this be sinus tachycardia?

Authors:  Shiu Yuen Man; Jonathan Tze Liang Choo; Shu-Ling Chong; Ronald Ming Ren Tan
Journal:  Singapore Med J       Date:  2022-01       Impact factor: 3.331

2.  Paroxysmal Supraventricular Tachycardia in Wolff-Parkinson-White Syndrome in a Newborn-Case Report and Mini-Review.

Authors:  Alina-Costica Luca; Alexandrina-Stefania Curpan; Ingrith Miron; Emma Oana Horhota; Alin-Constantin Iordache
Journal:  Medicina (Kaunas)       Date:  2020-11-05       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.